Gene mutations in the P53 pathway are considered early biological events in CRC (Calibasi-Kocal et al., 2021; Choi et al., 2021; Joh et al., 2021; Lopez, Bleich & Arthur, 2021). Here, TP53 is linked to colorectal carcinoma.